Accès ouvert
2026
article
OpenAlex
Giovanna Borriello, Clara Grazia Chisari, Davide Maimone, Francesca Matta et autres
Background Cladribine tablets are an oral short-course disease-modifying therapy (DMT) approved for the treatment of highly active relapsing multiple sclerosis (MS). While their efficacy has been demonstrated in clinical trials, limited real-world evidence is available on their impact on patient-reported outcomes (PROs) …
it, ch
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shalom Haggiag, Luca Prosperini, Massimo Filippi, Maria A. Rocca et autres
Importance: Early treatment choice in relapsing-remitting multiple sclerosis (RRMS) is prognostically crucial, yet robust comparative data on cladribine vs sphingosine-1-phosphate receptor modulators (S1PRMs) in treatment-naive patients with RRMS are limited. Objective: To compare the clinical effectiveness of cladribine vs S1PRMs in treatment-naive …
it, us, sk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Clara Grazia Chisari, Salvatore Lo Fermo, Salvatore Iacono, Giuseppe Rosario Schirò et autres
Ofatumumab (OFA), a fully human anti-CD20 monoclonal antibody, has shown promising efficacy in treating relapsing multiple sclerosis (RMS) by depleting B cells and reducing disease activity. This real-world, prospective, multicenter study evaluated the effectiveness and safety of OFA in treatment-naïve patients and …
it, us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli et autres
Background and Objectives It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19–related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and …
it
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Maria Pia Sormani, Irene Schiavetti, Doriana Landi, Luca Carmisciano et autres
Background: The MuSC-19 project is an Italian cohort study open to international partners that collects data on multiple sclerosis (MS) patients with COVID-19. During the second wave of the pandemic, serological tests became routinely available. Objective: To evaluate the seroprevalence of anti-SARS-CoV-2 …
it, br, tr
(code pays fourni par la source)